Retail subscription to 4.98M Fakeeh Care shares starts on TASI today

21/05/2024 Argaam Special
Logo ofDr. Soliman Abdulkader Fakeeh Hospital Co. (Fakeeh Care Group)

Logo of Dr. Soliman Abdulkader Fakeeh Hospital Co. (Fakeeh Care Group)


Retail investors start today, May 21, subscribing to about 4.98 million shares of Dr. Soliman Abdulkader Fakeeh Hospital Co. (Fakeeh Care Group) at SAR 57.50 each, as set in the book-building process. 

 

For More IPOs

 

The retail subscription will end on May 22. 

 

The Capital Market Authority (CMA) approved in March 2024 the company's request to float 49.8 million shares in an initial public offering (IPO), representing 21.47% of its post-IPO capital.

 

The offering will be through the issuance of 30 million new ordinary shares, paired with the sale of 19.8 million existing ordinary shares by the selling shareholders.

 

The newly-issued shares and the shares put for sale represent 12.93% and 8.53% of the post-IPO issued capital, respectively.

 

The company’s institutional offering, which ended last week, was 119x covered. 

 

The IPOs of Fakeeh Care and Miahona Co. are the third and fourth, respectively, this year, after Middle East Pharmaceutical Industries Co. (Avalon Pharma) flotations on January 30 and Modern Mills Co. on March 5.

 

Last year, the main market witnessed eight IPOs, namely, Morabaha Marina Financing Co. (MRNA), Mawarid Manpower Co.Jamjoom Pharmaceuticals Factory Co.First Milling Co., Lumi Rental Co.ADES Holding Co.SAL Saudi Logistics Services Co., and MBC Group.

 

Company Profile

 

Headquartered in Jeddah, Fakeeh Care is a closed joint-stock Saudi company, founded as a sole proprietorship in 1978.

 

The company's main activities include owning, operating, and managing hospitals, clinics, and other healthcare facilities, as well as medical education and training centers, laboratories, radiology centers, and pharmacies.

 

Fakeeh Care has three segments: medical services, education, as well as trade and retail trading.

 

The group is one of the few companies operating in the Saudi healthcare sector that has adopted the hub-and-spoke model of healthcare applied in the US.

 

This model involves establishing a multi-specialty hospital as a hub for an integrated range of medical services provided by the group as a whole, connected to multiple sub-entities such as medical centers, emergency services, and other sub-facilities that offer a variety of medical services.

 

The group, one of the largest private sector healthcare providers in the Kingdom, has been operating in this field for over 45 years. It also enjoys widespread recognition across the Gulf region.

 

Fakeeh Care has nine branches in various cities within the Kingdom, including Makkah, Jeddah, and NEOM.

 

Subsidiaries

 

The company owns three major subsidiaries and 11 minor subsidiaries. Below is a table detailing the major subsidiaries:

 

Subsidiaries

Subsidiary

Date of Registration in Commercial Register

Capital (SAR mln)

Ownership

 

Revenues 2022 (SAR mln)

Medical Fakeeh

2008

0.5

75%

307.5

Dr. Soliman Fakeeh Hospital-Riyadh

2016

571.1

60.56 %

9.46

Dr. Soliman Fakeeh Hospital-Jeddah

2003

1.0

80 %

87.7

 

Multispecialty Hospitals:

 

The group currently owns two multispecialty hospitals, namely Dr. Soliman Fakeeh Hospital in Jeddah and Dr. Soliman Fakeeh Hospital in Riyadh. Additionally, it operates Neom Hospital under the framework agreement for providing medical services signed with Neom Co. in March 2023.

 

The group also provides healthcare services through four medical centers that function as supporting branches within the hub-and-spoke model adopted by the group.

 

Multispecialty Hospitals

Details

Jeddah Hospital Complex

Riyadh Hospital

Inauguration

1978

2022

Employees

1,800 healthcare practitioners

200 doctors

Capacity

400 beds

134 clinics

108 ICU rooms

15 emergency operating rooms

185 beds

55 outpatient clinics

10 operations rooms

10 ICU rooms

10 cardiac ICU beds

 8 neonatal care rooms

Total Hospital Building Area

83,500 m²

5,000 m²

 

Current and Future Projects

 

The group is working on establishing three additional new hospitals in the Kingdom: a 200-bed tertiary healthcare hospital in Madinah, a 200-bed hospital in Makkah, and a 300-bed hospital in South Obhur, Jeddah. Additionally, there will be an additional expansion of the Jeddah Hospital Complex with an extra 140-bed capacity, bringing the total number of the group’s hospitals to six.

 

The number of beds in the group’s hospitals will gradually increase from 635 beds as of the company's publication date to 1,475 beds by 2028, upon completion of these projects.

 

As for medical centers, the group is working on establishing five additional new medical centers in the Kingdom, with an expected total cost of SAR 405 million.

 

These include Dr. Soliman Fakeeh Medical Center in Al Awali District, Makkah; Dr. Soliman Fakeeh Medical Center in North Obhur District, Jeddah; and Soliman Fakeeh Medical Center in Al-Hamra District, Riyadh, as well as two additional medical centers in Riyadh whose locations have yet to be determined.

 

This will bring the total number of healthcare centers owned by the group to 10 within the next three years, upon completion of these projects.

 

Company Profile

Company

Dr. Soliman Abdulkader Fakeeh Hospital Co.

Market

TASI

Core Activities

Healthcare

Capital Pre-IPO

SAR 200 mln

Post-IPO Capital

SAR 232 mln

Current Number of Shares

200 mln

Post-IPO Number of Shares

232 mln

Par Value

SAR 1/share

 

IPO Summary

Issue Percentage

21.47% of post-IPO capital

Offering Price

SAR 57.50

Number of Shares Offered

4.98 mln

Qualified Subscribers


Retail Investors

IPO Minimum Limit for Retail Investors

10 shares

IPO Maximum Limit for Retail Investors

250,000 shares

Retail Offering

May 21-22, 2024

Final Allocation

May 27, 2024

Surplus Refund (If any)

June 4, 2024

 

Additional Information

Financial Advisor, Lead Manager, Bookrunner and Underwriter

HSBC

Bookrunners

EFG Hermes KSA and ANB Capital

Receiving Banks

SAB, Alinma Bank, ANB, SNB. Al Rajhi Bank, and Bank AlJazira

 

Major Shareholders

Shareholders

Pre-IPO

Post-IPO

Number of Shares

(mln shares)

Ownership (%)

Number of Shares

(mln shares)

Ownership (%)

Mazen Soliman Abdulkader Fakeeh

79.98

39.99 %

71.42

 30.79%

Ammar Soliman Abdulkader Fakeeh

79.98

39.99 %

71.42

 30.79%

Manal Soliman Abdulkader Fakeeh

39.99

20.00 %

35.71

15.39 %

Treasury Shares*

--

--

2.00

0.86 %

Employee Investment Fund Allocated Shares

--

--

1.60

0.69 %

Public

--

--

49.80

21.47 %

Total

200.0

100 %

232.0

100 %

*The company’s shareholders approved the issuance and retention of shares as treasury shares, which were allocated to the Employee Stock Incentive Program (ESIP) of the company and its subsidiaries.

Comments {{getCommentCount()}}

Be the first to comment

loader Train
Sorry: the validity period has ended to comment on this news
Opinions expressed in the comments section do not reflect the views of Argaam. Abusive comments of any kind will be removed. Political or religious commentary will not be tolerated.